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Abstract 
Understanding the processes and events that occur when a cell undergoes a prelethal injury or that lead the cell to death following a 
lethal injury has been the aim of our research for a number of years. Throughout this period much has been learned, recently at rapid 
rates, not only by us but by many other investigators as well. Based on the data gathered, we proposed a working hypothesis over a 
decade ago and have since continually updated it as new experimentation is performed. Our laboratory has focused particularly on the role 
of cytoplasmic ionized calcium ([Ca 2+ ]i) and the effects of its deregulation on prelethal events, including oncosis and apoptosis, and 
lethal events (necrosis) following cell death. [Ca2+] i appears to be a major link and signalling event. Understanding the mechanisms 
involved by using a variety of in vivo and in vitro models, coupled with state-of-the-art methodologies, should now allow us to prevent 
cell death by killing cells when necessary through gene therapy and cancer chemotherapy. 
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1. Introduction 
The purpose of this paper is to consider the role of 
altered ionized intracellular calcium ([Ca 2+ ]i) regulation in 
the pathogenesis and altered physiology of cell injury and 
cell death, including apoptosis, oncosis, and necrosis. We 
will consider the responses of mammalian cells to lethal 
injury and the role of calcium regulation in relation to 
other intracellular signalling in the events that follow a 
lethal injury. 
2. Definitions of cell injury and cell death 
Following a lethal injury, three phases of cellular reac- 
tion occur: the prelethal phase; the phase of cell death; 
and the phase of necrosis (for reviews, see refs. [1,2]). The 
prelethal phases include changes that occur prior to the 
'point of cell death' and are potentially reversible. Two 
principal patterns of change are currently identified, 
namely, oncosis and apoptosis. 
Abbreviations: CPP32, apopain; CrmA, cowpox virus serpin; ICE, 
interleukin-1/3 converting enzyme; JNK, Jun N-terminal kinase; MAP, 
mitogen-activated protein; ARP, polyadenylate ribose polymerase. 
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In oncosis [3-7], the cells undergo rapid swelling with 
dilution of the cytosol, formation of cytoplasmic blebs at 
the plasmalemmal surface, dilatation of the endoplasmic 
reticulum (ER), mitochondrial condensation followed by 
inner compartment swelling, dilatation of ER and Golgi 
components, and nuclear chromatin clumping. In the case 
of types of injury that can be removed, such as complete 
anoxia or ischemia, all of these changes rapidly reverse to 
the normal phenotype. 
In contrast, the cells in apoptosis are typically shrunken 
with densification of the cytosol, more extreme clumping 
of nuclear chromatin, formation of even larger cytoplasmic 
blebs, and nuclear irregularities; changes in the mitochon- 
dria are similar with initial condensation followed by 
swelling [8]. 
At the time of cellular death, the changes can be 
dramatic by time-lapse cinematography (Trump, B.F., un- 
published observations) and include interruptions of the 
continuity of the plasma membrane with escape of cytoso- 
lic enzymes to the extracellular space and staining of the 
nuclei with Trypan blue or the fluorescent dye, propidium 
iodide. In the phase of necrosis, the changes are similar 
following either apoptosis or oncosis with the exception 
that, in the case of apoptosis occurring in vivo, many of 
the changes occur in fragments of cells or intact cells 
within the phagolysosome of adjacent parenchymal or 
mesenchymal cells. 
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In necrosis, the changes continue to progress [1,2]. 
Interruptions in plasmalemmal continuity are seen and 
often specialized surface structures, uch as microvilli, are 
totally distorted and form complex interlocking whorls 
resembling myelin figures. The blebs still persist, although 
many blebs have undergone fragmentation and appear as 
nearby debris. The nuclear chromatin clumping continues 
and, in addition, karyolysis begins with increased issolu- 
tion of nuclear DNA. The mitochondria remain markedly 
swollen, and contain one or two types of densities. The 
first type, so-called flocculent densities, are common to all 
types of necrosis and consist of aggregated dense intrama- 
trical material composed of denatured matrical proteins; 
their accumulation is a reliable morphologic indicator of 
cell death and necrosis. In the second type, precipitates of 
calcium phosphate occur following types of injury that do 
not directly interfere with mitochondrial calcium uptake, 
and, in large amounts, transform to calcium hydroxyapatite 
crystals. 
3. Experimental approach 
We have followed an experimental pproach to eluci- 
date the role of calcium [4,5,7] and cell injury as follows: a 
series of models, including toxic and others, were chosen 
to represent the major types of initial injury seen in human 
disease. These models have included ischemia; anoxia; 
treatment with carcinogens; and treatment with model 
toxins with primary characterized interactions such as inhi- 
bition of electron transport and oxidative phosphorylation; 
changes in cell membrane permeability, such as activation 
of the C5-9 components of complement; use of ionophores 
including those for calcium; modification of calcium trans- 
port in internal stores, such as thapsigargin; oxidant injury 
using hydrogen peroxide or superoxide generated by the 
xanthine/xanthine oxidative system; and transfection of 
genes to modify the reaction to injury or to modify cellular 
defenses. In many cases, these have been studied both in 
vivo and in vitro whenever possible. In general, however, 
to utilize modem technology including fluorescent probes 
and related technologies, many of the experiments have 
been carried out on primary cultures or cell lines in vitro. 
Much of the emphasis of our laboratory has been on 
studies of the proximal tubule of the kidney; however, we 
will compare these findings with those experiments per- 
formed by other laboratories and those using other cell 
systems. 
4. Relationship of changes to altered [Ca z + ]i 
4.1. Source of increased [Ca 2 + ]i 
Following injury, increases of [Ca2+] i can be rapid, 
occurring in some cases within seconds. The increased 
[Ca2+] i can result from influx of calcium from the extra- 
cellular space, from redistribution of intracellular stores, or 
often from both sources including so-called calcium-in- 
duced calcium release [9]. Increased levels of [Ca2+] i are 
commonly measured by preloading the cells with fluores- 
cent probes uch as Fura 2 for digital imaging fluorescence 
microscopy (DIFM) or Fluo-3 and related compounds for 
confocal microscopy [10,11]. The [Ca2+]i can be imaged 
or ratioed and measurements plotted directly using a pho- 
ton counter. 
4.2. Oncosis 
4.2.1. Swelling 
Cytoplasmic swelling in oncosis is marked and begins 
at an initial rate which is dependent on the type of injury. 
With direct damage to the cell membrane, e.g., comple- 
ment or mechanical damage, this occurs very rapidly; with 
inhibition of energy metabolism limiting the supply of 
ATP and inhibiting the Na+/K+-ATPase, the change oc- 
curs progressively, but more slowly [12]. The swelling is 
due primarily to increased Na ÷ accompanied by increased 
C1- and followed by water with accompanying loss of K ÷. 
As [Na2+] i increases in many cells including the renal 
epithelium, Na+/Ca 2÷ exchange is limited and [Ca2+]i 
increases as well. Obviously, with inhibition of ATP syn- 
thesis in mitochondria nd glycolysis, the plasmalemmal 
Ca2+-ATPase is also inactive and, with direct membrane 
damage, direct Ca 2÷ influx from the extracellular space 
Occurs .  
4.2.2. Bleb formation 
Cytoplasmic bleb formation occurs very early during 
the development of oncosis. These blebs are typically clear 
and often have a band of actin at the base. Using time-lapse 
cinematography, these blebs can be seen to form and 
reform several times during the immediate injury response. 
Morphologically, these blebs are associated with substan- 
tial modification of the cytoskeleton, including both tubu- 
lin and actin. By electron microscopy, the blebs are clear 
with no evidence of cytoskeletal elements between the 
remaining cytosol and the plasma membrane. Using im- 
munocytochemistry, it is apparent that the actin appears to 
detach from the cell membrane forming a band across the 
base of the bleb. As these blebs are observed to expand 
and contract and often detach, this is considered in our 
hypothesis to relate to contraction and relaxation of actin 
and modification of tubulin prior to release. It is our 
hypothesis that these actin changes are related to protease 
activity, including Ca 2+- activated proteases, as pretreat- 
ment with protease inhibitors greatly modifies the bleb 
formation [13]. In addition calcium-binding proteins, such 
as calmodulin and S-100 proteins, may contribute. A 
threshold of 300-400 mm [Ca 2+ ]i has been suggested for 
bleb formation [14]. 
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4.2.3. Mitochondrial changes 
The initial condensation of mitochondria has been cor- 
related with inhibition of ATP synthesis. The later inner 
compartment swelling is the consequence of the mitochon- 
drial permeability transition which is induced by increased 
[ Ca2 + ]i. 
4.2.4. Nuclear changes 
In the early stages of oncosis, there is evident nuclear 
chromatin clumping along the nuclear envelope and around 
the nucleolus, resulting in clarification of the remaining 
nucleoplasm. This aggregation is clearly reversible and 
restoring or adding the injury can result in several rever- 
sals of this phenomenon. Although the mechanism of this 
phenomenon is presently unknown, it is clear from a 
number of our experiments hat reduction of intracellular 
pH can result in nuclear chromatin condensation and since 
reduction of cytosolic pH is a very common early reaction, 
we hypothesize that pH reduction through protein DNA 
interactions results in this change. 
4.3. Apoptosis 
4.3.1. Cellular shrinkage 
Cellular shrinkage undoubtedly is due to loss of ions, 
predominantly K + and CI- followed by water ion regula- 
tion and has been shown to require phosphorylated ion 
transport systems; furthermore, the K ÷ channels in many 
cells are calcium-sensitive. Our hypothesis is that early 
increases of [Ca 2+ ]i stimulate K + loss and shrinkage prior 
to cell death. It has been shown by Bortner and Cidlowski 
[15] that lymphocytes xpressing Bcl-2 become resistant to 
dexamethasone-induced apoptosis, while lymphocytes ex- 
posed to hypertonic onditions without additional Bcl-2 
initiate DNA fragmentation. Thus, this area of volume 
regulations may be an important defense and control mech- 
anism involving cell death, but requires additional study. 
4.3.2. Cytoplasmic blebs 
The bleb formation in apoptosis also undoubtedly in- 
volves regulation of cytoskeletal membrane attachment, 
but the blebs are different from those seen in oncosis in 
that they contain abundant cytoplasm and cytoplasmic 
organelles rather than being watery. Further detailed inves- 
tigations are needed on the role of cytoskeletal calcium 
interactions. 
4,3.3. Mitochondrial changes 
Mitochondrial changes are similar to those seen with 
oncosis except hat the shrinkage of mitochondria in the 
condensed phase is somewhat more severe. Mitochondria 
undergo swelling prior to cell death in apoptosis. 
4.3.4. Nuclear changes 
Nuclear changes include extreme chromatin clumping 
and irregularity of nuclear contour. The DNA fragmenta- 
tion appears to be of different pattems and different cell 
types and may or may not always be calcium-regulated. 
Intemucleosomal fragmentation may be a late event. An 
early formation of large fragments apparently requires 
protease activity in addition to DNAse. 
4.4. Necrosis 
4.4.1. Plasmalemmal interruption and blebbing 
The interruption of plasmalemmal continuity which re- 
sults in trypan blue and propidium iodide staining is 
deemed to be secondary to Ca 2+ activation of phospholi- 
pase A phosphorylation through the action of kinases uch 
as MAP kinase. In time-lapse cinematography of apoptosis 
and oncosis, we have observed that one or more large 
terminal blebs often form around the time of cell death. 
These may well have a relationship to the breaks in 
plasmalemmal continuity seen by electron microscopy. 
4.4.2. Mitochondrial changes 
In necrosis, the mitochondria remain swollen and ex- 
hibit aggregation of matrical proteins, so-called 'flocculent 
densities'. In addition, there is fragmentation f the outer 
membrane. 
In certain types of injury, calcium phosphate deposits 
occur in the matrix in addition to the flocculent densities. 
This involves active uptake of Ca 2+ by the mitochondria 
from the cytosol and, therefore, is limited to injuries such 
as complement activation or other primary modification of 
the plasmalemma which leave the mitochondrial transport 
capability intact for a time. 
4.4.3. Nuclear digestion 
As the cell passes the 'point of no return', the clumped 
nuclear chromatin is progressively digested, resulting in 
blurred profiles in electrophoresis and loss of staining with 
cationic probes or dyes. This has been termed 'karyolysis' 
as ultimately only a nuclear ghost remains. 
5. Genetic regulation and signalling 
5.1. Pro-death genes 
5.1.1. Immediate-early genes 
The induction of a series of intermediate-early genes 
including c-fos, c-jun, NFKB, and c-myc characterize many 
types of acute lethal injury. These genes can be induced 
within 15 min or less, as in the case of c-fos and c-jun, and 
are evidently induced even in cells which are destined to 
die within 1 or 2 h. Following at least some types of 
injury, e.g., oxidant stress, the induction of these genes is 
Ca2+-dependent [16]. The function of these early genes, 
apart from inducing later genes including metalloproteases, 
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is not clear in the sense that in some cases these may lead 
to pathways of cell death while in others they may be 
preparatory for cell division and regeneration i the event 
that cell death does not occur. C-jun, in particular, has 
been identified as a pathway toward apoptosis and under 
some conditions overexpression f c-myc may be as well. 
This is further emphasized in the discussion of the kinase 
pathways below. Work with antisense RNA in some sys- 
tems has shown that failure to express c-jun can protect 
against cell death. Somewhat later, there is Ca2+-depen- 
dent induction of hsp70 which appears to protect against 
subsequent lethal injury [17]. 
rapid entry of Ca 2+ from the extracellular space and result 
in the consequences mentioned above. 
5.1.5. Others 
There is an expanding list of other genes whose func- 
tion appears to relate to cell death. One of these, ced-4, 
described in nematodes has been suggested to be a cal- 
cium-binding protein with an EF hand-like domain [26]. Its 
exact function and relationship to [Ca 2÷ ]i remain to be 
determined. Other calcium-binding proteins, including the 
S-100 family, have been observed to initiate apoptosis 
[27-29]. 
5.1.2. p53 - gadd and waf 
Among the functions of wild-type p53 is induction of 
mitotic arrest and acute cell death [18]. Microinjection of 
p53 into cultured cells commonly results in apoptosis and 
cell killing. Mutant p53, as seen in many forms of human 
neoplasia, does not exhibit his property. The precise mode 
of action of p53 is similarly not well understood. Although 
the relationship between p53 status and [Ca2+] i is incom- 
pletely understood, Weinberg et al. [19] noted that in 
combination with v-rasHa, keratinocytes deficient in p53 
shared decreased Ca2+-induced terminal differentiation. 
Among the later genes induced by activated p53 are 
gadd45 and waf(p21) [20,21]. In some experiments, 
waf(p21) has been shown to be involved in initiation of 
cell killing, though its exact relationship to the final or 
execution phase is not known. 
5.1.3. Proteases and phospholipases 
Beginning with the identification of the pro-death gene 
ced -3 in the nematode C. elegans, an entire family of 
proteases has been identified which appear to be late in the 
pathway leading to cell death [22-24]. The role of these 
proteases and cytoskeletal lterations and bleb formation 
was mentioned above. It has been shown that protease 
inhibitors can protect against both apoptosis and oncosis. 
The exact relationships in the final execution phase remain 
under study. 
5.1.4. The Degenerin gene family 
Although most of the programmed cell death in C. 
elegans development involves apoptosis, mutations in two 
genes, mec-4 and deg-1, result in oncosis followed by cell 
death (see review by Lints and Driscoll [25]). Lints and 
Driscoll [25] have suggested that these degenerin proteins 
might constitute an ion channel which, in the presence of 
mutations, may remain open. In this way, therefore, it 
would be comparable to activation of C5-9 or the effects 
of PCMBS in mammalian cells. Although the character- 
istics of the channel are presently unknown, the model 
proposed by Lints and Driscoll would clearly permit the 
5.2. Anti-death genes 
Experiments in nematodes have also indicated the pres- 
ence of anti-death genes. These led to the identification of 
ced-9 and later its mammalian homologue, bcl-2, which 
now are seen as part of a rapidly growing family of genes 
determining cell survival or cell death [30]. The gene bcl-2 
has received considerable attention regarding its mode of 
action. The dimensions of its protective action remain to 
be completely defined but we suggest that it protects 
against both apoptosis and oncosis. Mechanisms that have 
been suggested for its protective action include anti-oxi- 
dant properties, interference with signalling pathways, and 
modification of intracellular calcium regulation [31,32]. 
We have studied NRK cells (normal rat kidney proximal 
tubular epithelium) transfected with bcl-2 in order to ex- 
amine the reaction to injury. Clearly it is protective against 
oxidant injury and clearly the response of [Ca2+] i is 
greatly modified [33]. We suggest hat bcl-2 modifies the 
regulation of [Ca2+]i possibly involving Ca transport sys- 
tems in mitochondria, plasma membrane, or ER. 
5.3. Cell death signalling pathways 
Clearly, the signalling pathways that lead through onco- 
sis or apoptosis to cell death need to be determined. 
Progress is so rapid in this field that it is difficult to make 
any predictions. However, our current knowledge of im- 
mediate-early genes and protein kinase pathways provide 
important clues as does the determination f the morphol- 
ogy seen in apoptosis and oncosis. Experience with time- 
lapse cinematography of oncosis and apoptosis clearly 
show marked morphologic hanges during the earliest 
phases. Linkage between plasmalemmal nd cytoskeletal 
change may well provide a direct linkage between mor- 
phology and signalling. Faux and Scott [34] recently 
pointed out that 'approx. 300 of the anticipated 2000 
protein kinase and 1000 phosphatase genes have been 
identified' and proposed a morphologic/functional model 
of signalling that depends on kinase anchoring and scaf- 
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Fig. 1. Diagram illustrating our current working hypothesis ofthe major events leading from cell injury to cell death, focusing on the role of lea 2+ ]i- Some 
of the major categories of injury are shown at the top of the figure. Decreased and absent [ATP]i commonly results from complete ischemia, noxia, or 
treatment with inhibitors of ATP synthesis ncluding potassium cyanide, carbon monoxide, fluoride, and iodoacetic acid. Increased plasma membrane 
permeability commonly results from the immune response, .g., activation of complement or T-cell release of perforin, or from treatment with a variety of 
toxins including mercuric salts, ionophores, ormechanical damage. Growth factor deprivation is often studied in vitro though in vivo it does occur with 
neuronal damage. In oncosis, the early events involve cell swelling because of increased [Na+]i accompanied byC1- and water. This can result either 
from increased plasmalemmal permeability ordecreased [ATP] i resulting in inactivation of Na +, K+-ATPase. Increased [Na+]i can also contribute to 
increased [Ca 2+ ]i through decreased Na+/Ca 2+ exchange. In apoptosis, the initial events include cellular shrinkage, implying loss of ions in particular 
K + and CI-. The mechanism ofthe shrinkage is not presently known although increased [Ca 2+ ]i might contribute hrough activation of K + channels. The 
initial increase of [Ca 2+ ]i can result from influx from the extracellular space or from redistribution from intracellular stores. Following the increase, several 
prinicipal pathways seem to le~d to the reversible and irreversible changes as shown. Also illustrated in the diagram are the events that follow 
Ca2+-mediated activation of protein kinases, endonucleases, proteases, and phospholipases as discussed in the text. Our current hypothesis ofaltered gene 
expression related to cell death is shown near the bottom of the diagram. 
fold proteins. Of the anticipated 1000 phosphatase genes, 
we have observed that okadaic acid provides an excellent 
model of apoptosis and that modification of phosphatases 
1 and 2A result in dramatic morphologic and biochemical 
changes [35,36]. 
6. Hypothesis and conclusions 
Our current model of lethal cell injury and cell death is 
illustrated in Fig. 1. Deregulation of [Ca2+]i is shown as 
central to the signalling involved following several classes 
of lethal injury: inhibition of ATP synthesis as in the case 
of anoxia, ischemia, or mltochondrial inhibitors; increased 
plasmalemmal permeability as in the case of complement 
activation, cell-mediated killing, or many chemical toxins; 
or withdrawal of growth or trophic factors. In oncosis, the 
early cellular changes include increased [Na÷]i with con- 
comitant increase of water content and cellular swelling. 
This results from loss of ATP to power the Na÷/K+-pumps 
and/or  increased Na ÷ influx through the damaged plas- 
malemma. In apoptosis, the cells become shrunken and 
dense due to water loss, presumably the secondary result 
of efflux of intracellular ions such as K ÷ and C1-. This 
probably implies that ATP concentrations and synthesis 
remain active longer in this type of prelethal injury. 
Increased [Ca 2" ]i can result from influx from the extra- 
cellular space or from redistribution from other intra- 
cellular compartments such as the ER. A variety of effects 
follow such deregulation. These include activation of pro- 
teases, endonucleases, and phospholipases, all of which 
contribute to the cellular changes that occur during the 
prelethal phase. Some of the major activities are iUus- 
trated. Of special note are the changes that lead to activa- 
tion of genes and/or  gene products that trigger additional 
events, such as the ced 3 / ICE  protease family members, 
which appear to be close to the final phase of cell death. 
Also of note is that the lethal Ca2+-induced vents are 
antagonized by reducing pH [37]. 
In conclusion, much is being learned about the pro- 
cesses and events that lead to cellular death. Deregulation 
of [Ca 2+ ]i is an important link and signalling event in cells 
following a variety of injuries. Further understanding of 
these links should lead to improvements in prevention of 
cell death as well as to improved methods for kill ing cells 
as in cancer chemotherapy. 
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